4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001671311-25-000003
Chief Operating Officer sold 50,292 shares at an average $14.92 ($750,412)
- Chief Operating Officer acquired 50,292 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jarrett Jennifer Chief Operating Officer | 2025-10-06 | Option exercise 10b5-1 | +12,500 | $1.23 | $15,345 | 226,732 | D: show line 1 in the form |
| Jarrett Jennifer Chief Operating Officer | 2025-10-06 | Sale 10b5-1 | −12,500 | $14.54 | $181,801 | 214,232 | D: show line 2 in the form |
| Jarrett Jennifer Chief Operating Officer | 2025-10-08 | Option exercise 10b5-1 | +37,792 | $1.23 | $46,393 | 252,024 | D: show line 3 in the form |
| Jarrett Jennifer Chief Operating Officer | 2025-10-08 | Sale 10b5-1 | −37,792 | $15.05 | $568,611 | 214,232 | D: show line 4 in the form |
| Open-market sales · 50,292 sh · avg $14.92 · $750,412 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Jarrett Jennifer Chief Operating Officer | 2025-10-06 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 168,666 | D: show line 5 in the form | |||||
| Jarrett Jennifer Chief Operating Officer | 2025-10-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,792 | 130,874 | D: show line 6 in the form |
Loading xslF345X05/wk-form4_1759964895.xml…